SCHEMBL31348146

SCHEMBL31348146

O=C1c2ccccc2C(=O)N1CC[C@@H](O)CN1CCC(F)(c2cccc(C(F)(F)F)n2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
OPRM1 P35372 2/20 0.37
SIGMAR1 Q99720 1/20 0.37
KDM4E B2RXH2 6/20 0.36
MAOB P27338 4/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
UBE2N P61088 3/20 0.35
HTT P42858 3/20 0.35
MAPT P10636 1/20 0.35
LMNA P02545 2/20 0.34
RAD52 P43351 1/20 0.34
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
ADRB2 P07550 2/20 0.34
ADRB1 P08588 2/20 0.34
ADRB3 P13945 2/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31348197 0.83 CNR1 (0.33) OPRM1SIGMAR1DRD2DRD3ADRB1
SCHEMBL31348215 0.81 ALDH1A1 (0.37) ALDH1A1OPRM1SIGMAR1KDM4EMMP2
SCHEMBL31348264 0.81 OPRL1 (0.45) ALDH1A1OPRM1SIGMAR1KDM4EMMP2
SCHEMBL31348127 0.75 HTR1A (0.42) ALDH1A1KDM4EDRD2DRD3MAPK1
SCHEMBL31348249 0.75 HTR1A (0.56) DRD2HTR1A
SCHEMBL9725137 0.65 HTR1A (0.55) OPRM1LMNADRD2DRD3HTR1A
SCHEMBL31348261 0.65 SCN1A (0.43) ALDH1A1MMP2MMP9DRD2DRD3
SCHEMBL15779861 0.65 HTR1A (0.64) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL17578648 0.64 HTR1A (0.64) ALDH1A1MAPTLMNADRD3HTR1A
SCHEMBL6163213 0.64 DRD2 (0.69) ALDH1A1OPRM1KDM4EMAOBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025006982-A1 POTENT AND SELECTIVE DOPAMINE D3 RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2025-01-02 WO disclosed